SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin seeks more time from commerce ministry to complete project in Indore SEZ

20 Apr 2019 Evaluate

Lupin has sought more time from the commerce ministry to complete its project, with proposed investment of Rs 205.69 crore, in the Indore Special Economic Zone (SEZ). The company is setting up its pharma unit in Indore SEZ to manufacture pharmaceutical formulations - metered dose inhalers and dry powder inhalers.

The company’s plea for extension of time will be considered by the highest decision making body of SEZs - Board of Approval (BoA) in its meeting on April 22.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2494.25 -8.65 (-0.35%)
10-Jul-2026 09:52 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1938.15
Dr. Reddys Labs. 1241.80
Cipla 1443.80
Zydus Lifesciences 1152.50
Lupin 2494.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: